Medical device maker Becton Dickinson said on Tuesday it received additional orders from the United States and Canada governments for 177 million syringes and needles for COVID-19 vaccination programs.
The new order for 140 million syringes and needles brings Becton’s total U.S. orders to 190 million devices, while the new Canadian order for 37 million devices brings the country’s total orders to 75 million.
In early July, Becton said the U.S. government planned to invest $42 million to expand the company’s manufacturing capacity for syringes and needles to support COVID-19 vaccination efforts.
Get weekly health news
The company said it would start distributing the devices by the end of December 2020.
- University Bridge construction for Bus Rapid Transit plan starts in April
- Pilots say NAV Canada protocols not always followed, would like more robust staffing
- ‘Passing the buck’: Edmonton business deals with decades-long drainage problem
- Calgary mayor says ‘target’ of RCMP probe isn’t ‘past or present’ member of council
-
![]()
What we know about 2 pilots killed in Air Canada plane crash at LaGuardia Airport -
![]()
Quebec Government, Bill-21-supporting groups testify in favour of provincial secularism law -
![]()
Trump deploys ICE at US airports amid long lines due to partial gov’t shutdown -
![]()
Aid, volunteers arrive in Cuba on 1st flotilla amid energy crisis, U.S. oil blockade
Becton said in May it was preparing to ramp up manufacturing operations to handle demand for COVID-19 testing kits in the event of a second wave of infections during fall.
Last week, the U.S. government agreed to buy 2,000 of the company’s BD Veritor Plus Systems and 750,000 of its SARS-CoV-2 antigen test, as the country ramps up testing for the virus that has been spreading at an alarming rate.
Comments
Want to discuss? Please read our Commenting Policy first.